Abstract
Compensation of target motion during the delivery of radiotherapy has the potential to improve treatment accuracy, dose conformity and sparing of healthy tissue. We implement an online image guided therapy system based on soft tissue localization (STiL) of the target from electronic portal images and treatment aperture adaptation with a dynamic multi-leaf collimator (DMLC). The treatment aperture is moved synchronously and in real-time with the tumor during the entire breathing cycle.
The system is implemented and tested on a Varian TX clinical linear accelerator featuring an AS-1000 electronic portal imaging device (EPID) acquiring images at a frame rate of 12.86 Hz throughout the treatment. A position update cycle for the treatment aperture consists of 4 steps: in the first step at time t = t0 a frame is grabbed, in the second step the frame is processed with the STiL algorithm to get the tumor position at t = t0, in a third step the tumor position at t = t + δt is predicted to overcome system latencies and in the fourth step, the DMLC control software calculates the required leaf motions and applies them at time t = t + δt. The prediction model is trained before the start of the treatment with data representing the tumor motion. We analyze the system latency with a dynamic chest phantom (4D motion phantom, Washington University). We estimate the average planar position deviation between target and treatment aperture in a clinical setting by driving the phantom with several lung tumor trajectories (recorded from fiducial tracking during radiotherapy delivery to the lung).
DMLC tracking for lung SBRT without fiducial markers was successfully demonstrated. The inherent system latency is found to be δt = (230 ± 11) ms for a MV portal image acquisition frame rate of 12.86 Hz. The root mean square deviation between tumor and aperture position is smaller than 1 mm.
We demonstrate the feasibility of real-time markerless DMLC tracking with a standard LINAC-mounted (EPID).
Keywords: lung, markerless, real-time, DMLC, motion estimation, tracking, EPID, portal image, SBRT, beams-eye-view, radiotherapy
1. Introduction
Thoracic and abdominal tumors often exhibit large respiratory motion ranges (Ekberg et al. [5], Seppenwoolde et al. [25], Keall et al. [11]). Intrafractional target motion causes a blurring of the target dose distribution which necessitates the irradiation of additional normal tissue surrounding the tumor volume to achieve full dose coverage of the target. Stereotactic body radiation therapy (SBRT) for non-small cell lung cancers (NSCLC) has been found to be a promising alternative treatment option to surgery (Fakiris et al. [7], Nagata et al. [17]), particularly for early stage NSCLC and inoperable cases. However, radiation toxicity can be a concern (Timmerman et al. [28]). The grade of toxicity has been linked to the irradiated volume and the integrated dose to sensitive structures (e.g. chest wall) (Andolino et al. [1], Matsuo et al. [16]).
Beam tracking (Keall et al. [10]), can effectively “freeze” the tumor motion in the beam reference frame by following it with the treatment beam and can therefore potentially reduce the size of the irradiated volume and/or the maximal dose delivered to critical structures. The procedure may be divided into two separate steps:
A method for real-time target motion estimation.
A device to shift the radiation beam synchronized to the target position.
The main challenge for step (ii) is to develop a system with acceptable technical specifications concerning leaf position accuracy, velocity and response time. There are currently two research platforms (Tacke et al. [27], Sawant et al. [24]) that provide real-time adjustment of the treatment aperture in response to the signal of a motion capture device.
Other publications have utilized fiducial marker tracking for step (i). Both, the use of electromagnetically excitable markers (Calypso) as well as marker segmentation from x-ray fluoroscopy images have been tested (Sawant et al. [23], Krauss, Nill, Tacke and Oelfke [14]). Using the MV-EPID with soft tissue localization can avoid the patient’s discomfort and any risks associated with fiducial marker placement (including pneumothorax
2. Materials and Methods
2.1. System implementation on Varian platform
A system is presented integrating fast image acquisition, real-time markerless image-based target position estimation (Rottmann et al. [21]), a linear predictor and a DMLC tracking system developed for the Varian platform (Sawant et al. [24]). In Figure 1 a flowchart of this system is shown. In the following a brief overview of the components is given.
2.1.1. Image acquisition
A frame grabber was provided courtesy of Varian Medical Systems, Inc. along with an application programming interface (API) allowing direct random access memory (RAM) buffer access to images grabbed from the LINAC-integrated image acquisition system. When compared to saving the images first on disk (cf. Fledelius et al. [8], Poulsen et al. [19]), this can reduce the time ΔTaq needed for image acquisition and allows the seamless integration of the image acquisition process with the other components.
2.1.2. Soft Tissue Localization (STiL)
The STiL algorithm has been described in previous publications (Rottmann et al. [21]) and is embedded in a Matlab® GUI to have real-time visual feedback for the user. The GUI has an interface accepting incoming frame buffers from the frame grabber API. Figure 2 (right) shows the GUI during tracking of the phantom used in this study. The resulting target positions p(ti) (red arrow in the figure) are fed into a linear predictor that uses the first Nt positions for training. The forward predicted position p̂(ti+δts) is sent to the DMLC component which calculates and then requests the new leaf-positions by communication with the MLC controller.
2.1.3. Predictor
For any system attempting to compensate tumor motion by image guided target tracking there is an inherent implementation specific time interval that is needed for the process of image acquisition, position calculation and hardware adjustment. In the context of dynamic aperture adaptation we define the system latency δts to be the time interval needed for the aperture position to reach a given target position. The aperture will therefore reach the target position p(ti), calculated from an image acquired at time ti, at time t = ti + δts introducing a geometric error. The magnitude of this error naturally depends on δts and the target velocity.
To reduce the latency induced geometric error, we need to estimate for each target position p(ti) a future target position p̂(ti + τp). The underlying assumption in finding this estimate is that the target location at time (ti+τp) may be expressed as a function of the Np previous target positions {p(tj) | j = (i − Np), …, i}, i.e. we need to define an adequate prediction function
(1) |
Several techniques for constructing fp have been proposed and compared in the literature: Sharp et al. [26] compared linear prediction (LP) with an artificial neural network (ANN) and a Kalman filter (KF) using patient data traces as simulation input. Considering imaging frequencies of 1–30 Hz and latencies from 33–1000 ms they found ANN and LP to give similar results and consistently outperform KF. Ernst and Schweikard [6] proposed the use of support vector regression (SVR) and Ruan [22] proposed a kernel density (KD) based prediction algorithm. Krauss, Nill and Oelfke [13] implemented and compared LP, ANN, SVR and KD including extensive model parameter optimization on the same data set used by Sharp et al. [26] and Krauss, Nill and Oelfke [13]. They found the ANN algorithm to work best, closely followed by SVR and LP and all algorithms performing far better than KD.
Comparing the complexities of the algorithms, we have found linear (ridge) regression to be a rather fast and simple, yet still appropriate method for construction of fp (cf. Krauss, Nill and Oelfke [13]). In this case the prediction function fp can be explicitly written as
(2) |
if we define xi := (p(ti−Np), …, p(ti)). For practical purposes the constant term α0 can be omitted if we pre-process all input data to have a mean value of zero. Additionally we can neglect any kind of scaling differences between training data and testing data‡ if all input data is normalized to have a standard deviation of unity. The transformation is applied to each position p(ti) in the form of a sliding window operation using the Np previous positions to calculate the standard deviation σi and the mean value mi
(3) |
if we use
(4) |
Considering a set of Nt value pairs of training data: {(x̃i, ỹi) | i = 1, …, Nt} with normalized predicted positions ỹi = p̃(ti + τp) that may be calculated by linear interpolation, the weight vector α can be written as an analytic expression:
(5) |
Here X = (x̃1, …, x̃Nt)T ∈ ( × ) is a matrix containing in each row a training vector xi, Y = (ỹ1, …, ỹNp)T is a column vector containing the interpolated target positions at times (ti+τp) and λ is the Tikhonov regularization parameter, which helps to keep the matrix inversion numerically stable for the cases of a poorly conditioned X. There is one free model parameter (λ). Krauss, Nill and Oelfke [13] have found that a patient independent tuning of prediction model parameters is generally adequate, so we follow this approach and tune this parameter with traces that are not later used for prediction.
2.1.4. Dynamic MLC control
The updated aperture position is processed by dynamic multi-leaf collimator (DMLC) tracking software developed for the Varian platform. It has been described in detail by Sawant et al. [24].
2.2. Experimental demonstration with a dynamic motion phantom
We characterized the performance of the integrated system with dynamic phantom studies. For this we employed the Washington University’s 4D phantom, which consists of three orthogonally mounted translation stages that can be programmed to move a platform in an arbitrary 3 D trajectory (cf. Figure 2left). For the target we used a lung tumor model made by rapid prototyping from a resin and placed it on the phantom tray. The tumor model was modeled after a patient’s CT using the GTV outline (cf. Court et al. [4]). The phantom was mounted on the treatment couch of a Varian TX linear accelerator holding the target roughly at an isocentric position (SAD = 100). A circular treatment aperture covering the target completely was chosen and the EPID (AS-1000) was set up at SID = 180 cm, recording at 12.86 Hz with a pixel resolution of (0.43 × 0.43) mm in the isocenter plane.
2.2.1. System latency and its measurement
To determine the look-ahead time, the system latency is measured without the predictor. The dynamic phantom is programmed to drive in a sinusoidal motion with a cycle time of T = 4.5 s and a peak-to-peak amplitude of A = 20 mm in the superior-inferior direction, i.e. in the motion direction of the MLC leaves. With respect to motion range and cycle time, this scenario is a sufficiently realistic simulation of respiratory motion observed clinically during radiotherapy delivery (cf. Berbeco et al. [3]). Running the system without a prediction algorithm in place results in a shift between target position and aperture position of the MV beam that can be easily analyzed from the acquired portal images. Calculating the phase shift Δϕ between a sinusoidal fit to the target positions pgtv(ti) and a sinusoidal fit to the treatment aperture position pmlc(ti) yields then an estimate for the system latency:
(6) |
2.2.2. Geometric Accuracy with realistic phantom data
To quantify the geometric accuracy of the integrated tracking system (cf. Figure 1 ) three patient lung tumor trajectories were utilized (Berbeco et al. [3]). The trajectories were chosen from a data set of 17 patients that had underwent fiducial marker implantation before being treated for non-small cell lung cancer (NSCLC). The selection criterion was large tumor motion range and (for trajectory 1 and 3) irregularity because we expect these conditions to be the most challenging for MLC leaf travel velocity and predictor performance, respectively. The dynamic motion phantom was programmed with the superior-inferior component of the breathing trajectory. The predictor model was trained in a separate session before the radiation delivery to the phantom. The predictor look-ahead time was set equal to the previously measured system latency (τp = δts). An overview of all relevant predictor parameters is given in Table 1. For the phantom experiments, the first 100 data points were not latency corrected by the predictor because the prediction vector was chosen to be of this size (Np = 100). This length of time was chosen to have a sizable sample of points providing results with and without prediction. The timing requirements and alternate schemes are presented in the Discussion section (Section 4).
Table 1.
parameter | frame rate | τp = δts | λ | Np | Nt | Nwait | Ntest |
---|---|---|---|---|---|---|---|
value | 12.86 Hz | 250 ms | 0.025 | 100 | 450 | 100 | 450 |
We use the root mean square error (RMSE) as a measure for the deviation between tumor phantom location and treatment aperture location.
3. Results
3.1. System latency
We observed a system latency of δts = (230 ± 11) ms (see Eq. (6)) at an imaging frequency of 12.86 Hz for our experimental implementation. The MLC leaves were positioned in parallel to the dynamic phantom motion. The sinusoidal fits to target and treatment aperture position are shown in Figure 3.
3.2. Deviation between target and aperture position
The STiL algorithm operates in real-time and provides target positions to the predictor that allow the treatment aperture to follow the target motion, keeping the aperture centered on the target. The three sample breathing traces used in this study (for driving the dynamic phantom) are shown in Figure 4 with their respective histograms of geometric deviation between tumor and aperture position. It is apparent that the system latency can be effectively compensated. The observed deviations are in line with the geometric accuracy of the markerless soft tissue localization (STiL) algorithm. The overall geometric accuracy is found to be sub-millimeter for all three patient tumor motions. In our previous study, the STiL algorithm provided sub-millimeter localization (without DMLC motion). The histogram also clearly shows a shifts towards smaller deviations once the predictor has started operation. The results are summarized in Table 2. For the investigated traces it is shown that DMLC tracking with a linear predictor can substantially reduce the residual tumor motion.
Table 2.
trace | static beam RMSE [mm] |
DMLC RMSE [mm] |
DMLC + LP RMSE [mm] |
---|---|---|---|
| |||
1 | 3.4 ± 3.8 | 1.9 ± 1.9 | 0.9 ± 0.9 |
2 | 3.2 ± 3.2 | 1.4 ± 1.4 | 0.6 ± 0.6 |
3 | 2.4 ± 2.4 | 1.8 ± 1.8 | 0.7 ± 0.7 |
4. Discussion
In this paper we demonstrate the feasibility of using MV markerless lung tumor tracking in combination with a linear prediction filter to drive real-time dynamic multi-leaf collimator (DMLC) adaptation on a clinical linear accelerator. The presented system employs a previously published DMLC tracking code (Sawant et al. [24]) which we have combined with a markerless soft tissue localization (STiL) algorithm optimized for real-time operation. Furthermore we show that a linear prediction filter can substantially reduce geometric errors caused by the system’s inherent latency.
Using the same DMLC tracking code and similar equipment (Varian Trilogy) but no frame grabber Poulsen et al. [19] reported a system latency of about δts = (380±9) ms with a single marker segmentation algorithm. Krauss, Nill, Tacke and Oelfke [14] reported a system latency of 500 ms for their DMLC tracking implementation on the Siemens platform. We attribute our smaller system latency (230 ± 11) ms to the use of the frame grabber and our optimized motion estimation algorithm.
A linear prediction filter was implemented to further reduce the geometric error caused by the system latency. While linear prediction is known to perform less well with irregular breathing patterns, our small latency renders these differences insignificant (Krauss, Nill and Oelfke [13]). For the three lung tumor trajectories (recorded from patients during SBRT deliveries), we saw a reduction in geometric deviation by about 50% with the predictor.
Due to the use of MV-EPID images we can only calculate 2D motion information. However, the neglected direction (depth) has a very shallow dose falloff compared to the other two directions (Nill et al. [18]). Additionally, using the EPID does not give additional imaging dose to a patient (Kilby and Savage [12]). Other publications have suggested using the MV-EPID for lung tumor motion analysis (Richter et al. [20], Rottmann et al. [21], Arimura et al. [2]) and reported accuracy in retrospective user-dependent image analysis scenarios. The algorithm employed in this publication, however, operates fully automatic, i.e. finding landmarks and following these in real-time without prior knowledge or human interaction. The accuracy of the tracking algorithm is of the same range as reported in [21], i.e. better than 1 mm for a dynamic motion phantom.
The accuracy of any real-time tracking of tumors will depend on the fidelity of the localization algorithm. For our method, patient-specific and treatment-specific factors will have some influence on real-time localization due to the visibility of the tumor in MV images. The clinical effect of these factors will be investigated in a separate study of a large patient cohort. The purpose of the current study is to demonstrate the integration of EPID imaging, tumor localization, prediction and DMLC motion on a clinical linear accelerator in a real-time implementation. Prior to clinical application with patients, several challenges will be addressed, including quality assurance, treatment planning and methods for improving the MV imaging capabilities.
While the phantom employed in this demonstration is not anthropomorphic, the tumor model itself is, to our knowledge, more realistic than any other that has been used for this purpose. While the size of the tumor model used in this study is somewhat larger than most tumors that are treated with SBRT, tumor model size will not affect the results in this phantom study.
A pre-treatment training data set can be derived prior to the tracking session. External surrogate data from 4DCT acquisition or tumor motion estimation from pre-treatment cone-beam CT (CBCT) can be used for this purpose [15]. Phase lags between external surrogate motion and tumor motion [9] do not affect the training of the predictor as only the motion pattern information is needed. At the beginning of the tracking session, a period of at least one breathing cycle is required for establishing the tumor trajectory history vector. As SBRT treatments have 4–6 minutes of beam-on time, we don’t see this as a substantial limitation.
5. Conclusions
We have demonstrated fully automatic, real-time, markerless DMLC tracking on a clinical LINAC. Furthermore, we have shown that a linear prediction algorithm can eliminate the system latency, resulting in sub-millimeter accuracy.
Acknowledgments
This work was supported by awards R21CA156068 and R01CA93626 from the National Cancer Institute and NHMRC Australia Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Also, we would like to thank Varian Medical Systems, Inc. for providing us with the frame grabber soft- and hardware.
Footnotes
This is particularly convenient if other sources of input are used in a complementary way as for instance external surrogate data for training the model.
References
- 1.Andolino DL, Forquer JA, Henderson MA, Barriger RB, Shapiro RH, Brabham JG, Johnstone PAS, Cardenes HR, Fakiris AJ. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. Int J Radiat Oncol Biol Phys. 2011;80(3):692–697. doi: 10.1016/j.ijrobp.2010.03.020. URL: http://dx.doi.org/10.1016/j.ijrobp.2010.03.020. [DOI] [PubMed] [Google Scholar]
- 2.Arimura H, Egashira Y, Shioyama Y, Nakamura K, Yoshidome S, Anai S, Nomoto S, Honda H, Toyofuku F, Higashida Y, Onizuka Y, Terashima H. Computerized method for estimation of the location of a lung tumor on epid cine images without implanted markers in stereotactic body radiotherapy. Phys Med Biol. 2009;54(3):665–677. doi: 10.1088/0031-9155/54/3/013. URL: http://dx.doi.org/10.1088/0031-9155/54/3/013. [DOI] [PubMed] [Google Scholar]
- 3.Berbeco RI, Nishioka S, Shirato H, Chen GTY, Jiang SB. Residual motion of lung tumours in gated radiotherapy with external respiratory surrogates. Phys Med Biol. 2005;50(16):3655–3667. doi: 10.1088/0031-9155/50/16/001. URL: http://dx.doi.org/10.1088/0031-9155/50/16/001. [DOI] [PubMed] [Google Scholar]
- 4.Court LE, Seco J, Lu XQ, Ebe K, Mayo C, Ionascu D, Winey B, Giakoumakis N, Aristophanous M, Berbeco R, Rottman J, Bogdanov M, Schofield D, Lingos T. Use of a realistic breathing lung phantom to evaluate dose delivery errors. Med Phys. 2010;37(11):5850–5857. doi: 10.1118/1.3496356. [DOI] [PubMed] [Google Scholar]
- 5.Ekberg L, Holmberg O, Wittgren L, Bjelkengren G, Landberg T. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol. 1998;48(1):71–77. doi: 10.1016/s0167-8140(98)00046-2. [DOI] [PubMed] [Google Scholar]
- 6.Ernst F, Schweikard A. Forecasting respiratory motion with accurate online support vector regression (svrpred) Int J Comput Assist Radiol Surg. 2009;4(5):439–447. doi: 10.1007/s11548-009-0355-5. URL: http://dx.doi.org/10.1007/s11548-009-0355-5. [DOI] [PubMed] [Google Scholar]
- 7.Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase ii study. Int J Radiat Oncol Biol Phys. 2009;75(3):677–682. doi: 10.1016/j.ijrobp.2008.11.042. URL: http://dx.doi.org/10.1016/j.ijrobp.2008.11.042. [DOI] [PubMed] [Google Scholar]
- 8.Fledelius W, Keall PJ, Cho B, Yang X, Morf D, Scheib S, Poulsen PR. Tracking latency in image-based dynamic mlc tracking with direct image access. Acta Oncol. 2011;50(6):952–959. doi: 10.3109/0284186X.2011.581693. URL: http://dx.doi.org/10.3109/0284186X.2011.581693. [DOI] [PubMed] [Google Scholar]
- 9.Ionascu D, Jiang SB, Nishioka S, Shirato H, Berbeco RI. Internal-external correlation investigations of respiratory induced motion of lung tumors. Med Phys. 2007;34(10):3893–3903. doi: 10.1118/1.2779941. [DOI] [PubMed] [Google Scholar]
- 10.Keall PJ, Kini VR, Vedam SS, Mohan R. Motion adaptive x-ray therapy: a feasibility study. Phys Med Biol. 2001;46(1):1–10. doi: 10.1088/0031-9155/46/1/301. [DOI] [PubMed] [Google Scholar]
- 11.Keall PJ, Mageras GS, Balter JM, Emery RS, Forster KM, Jiang SB, Kapatoes JM, Low DA, Murphy MJ, Murray BR, Ramsey CR, Herk MBV, Vedam SS, Wong JW, Yorke E. The management of respiratory motion in radiation oncology report of aapm task group 76. Med Phys. 2006;33(10):3874–3900. doi: 10.1118/1.2349696. [DOI] [PubMed] [Google Scholar]
- 12.Kilby W, Savage C. The effect of the varian amorphous silicon electronic portal imaging device on exit skin dose. Phys Med Biol. 2003;48(19):3117–3128. doi: 10.1088/0031-9155/48/19/002. [DOI] [PubMed] [Google Scholar]
- 13.Krauss A, Nill S, Oelfke U. The comparative performance of four respiratory motion predictors for real-time tumour tracking. Phys Med Biol. 2011;56(16):5303–5317. doi: 10.1088/0031-9155/56/16/015. URL: http://dx.doi.org/10.1088/0031-9155/56/16/015. [DOI] [PubMed] [Google Scholar]
- 14.Krauss A, Nill S, Tacke M, Oelfke U. Electromagnetic real-time tumor position monitoring and dynamic multileaf collimator tracking using a siemens 160 mlc: geometric and dosimetric accuracy of an integrated system. Int J Radiat Oncol Biol Phys. 2011;79(2):579–587. doi: 10.1016/j.ijrobp.2010.03.043. URL: http://dx.doi.org/10.1016/j.ijrobp.2010.03.043. [DOI] [PubMed] [Google Scholar]
- 15.Lewis JH, Li R, Watkins WT, Lawson JD, Segars WP, Cervino LI, Song WY, Jiang SB. Markerless lung tumor tracking and trajectory reconstruction using rotational cone-beam projections: a feasibility study. Phys Med Biol. 2010;55(9):2505–2522. doi: 10.1088/0031-9155/55/9/006. URL: http://dx.doi.org/10.1088/0031-9155/55/9/006. [DOI] [PubMed] [Google Scholar]
- 16.Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Ueki N, Miyagi K, Norihisa Y, Mizowaki T, Nagata Y, Hiraoka M. Dose–volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(4):e545–e549. doi: 10.1016/j.ijrobp.2012.01.018. URL: http://dx.doi.org/10.1016/j.ijrobp.2012.01.018. [DOI] [PubMed] [Google Scholar]
- 17.Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Clinical outcomes of a phase i/ii study of 48 gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427–1431. doi: 10.1016/j.ijrobp.2005.05.034. URL: http://dx.doi.org/10.1016/j.ijrobp.2005.05.034. [DOI] [PubMed] [Google Scholar]
- 18.Nill S, Unkelbach J, Dietrich L, Oelfke U. Online correction for respiratory motion: evaluation of two different imaging geometries. Phys Med Biol. 2005;50(17):4087–4096. doi: 10.1088/0031-9155/50/17/012. URL: http://dx.doi.org/10.1088/0031-9155/50/17/012. [DOI] [PubMed] [Google Scholar]
- 19.Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ. Detailed analysis of latencies in image-based dynamic mlc tracking. Med Phys. 2010;37(9):4998–5005. doi: 10.1118/1.3480504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Richter A, Wilbert J, Baier K, Flentje M, Guckenberger M. Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:618–627. doi: 10.1016/j.ijrobp.2009.11.028. URL: http://dx.doi.org/10.1016/j.ijrobp.2009.11.028. [DOI] [PubMed] [Google Scholar]
- 21.Rottmann J, Aristophanous M, Chen A, Court L, Berbeco R. A multi-region algorithm for markerless beam’s-eye view lung tumor tracking. Phys Med Biol. 2010;55(18):5585–5598. doi: 10.1088/0031-9155/55/18/021. URL: http://dx.doi.org/10.1088/0031-9155/55/18/021. [DOI] [PubMed] [Google Scholar]
- 22.Ruan D. Kernel density estimation-based real-time prediction for respiratory motion. Phys Med Biol. 2010;55(5):1311–1326. doi: 10.1088/0031-9155/55/5/004. URL: http://dx.doi.org/10.1088/0031-9155/55/5/004. [DOI] [PubMed] [Google Scholar]
- 23.Sawant A, Smith RL, Venkat RB, Santanam L, Cho B, Poulsen P, Cattell H, Newell LJ, Parikh P, Keall PJ. Toward submillimeter accuracy in the management of intrafraction motion: the integration of real-time internal position monitoring and multileaf collimator target tracking. Int J Radiat Oncol Biol Phys. 2009;74(2):575–582. doi: 10.1016/j.ijrobp.2008.12.057. URL: http://dx.doi.org/10.1016/j.ijrobp.2008.12.057. [DOI] [PubMed] [Google Scholar]
- 24.Sawant A, Venkat R, Srivastava V, Carlson D, Povzner S, Cattell H, Keall P. Management of three-dimensional intrafraction motion through real-time dmlc tracking. Med Phys. 2008;35(5):2050–2061. doi: 10.1118/1.2905355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Seppenwoolde Y, Shirato H, Kitamura K, Shimizu S, van Herk M, Lebesque JV, Miyasaka K. Precise and real-time measurement of 3d tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53(4):822–834. doi: 10.1016/s0360-3016(02)02803-1. [DOI] [PubMed] [Google Scholar]
- 26.Sharp GC, Jiang SB, Shimizu S, Shirato H. Prediction of respiratory tumour motion for real-time image-guided radiotherapy. Phys Med Biol. 2004;49(3):425–440. doi: 10.1088/0031-9155/49/3/006. [DOI] [PubMed] [Google Scholar]
- 27.Tacke M, Nill S, Oelfke U. Real-time tracking of tumor motions and deformations along the leaf travel direction with the aid of a synchronized dynamic mlc leaf sequencer. Phys Med Biol. 2007;52(22):N505–N512. doi: 10.1088/0031-9155/52/22/N01. URL: http://dx.doi.org/10.1088/0031-9155/52/22/N01. [DOI] [PubMed] [Google Scholar]
- 28.Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, Fletcher J. Excessive toxicity when treating central tumors in a phase ii study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833–4839. doi: 10.1200/JCO.2006.07.5937. URL: http://dx.doi.org/10.1200/JCO.2006.07.5937. [DOI] [PubMed] [Google Scholar]